Temprian Therapeutics: developing a gene-based treatment for vitiligo

Nature, Published online: 30 June 2020; doi:10.1038/d41586-020-01808-5

A modified protein to disrupt the autoimmune cascade that can lead to the skin-pigment condition makes the company a finalist for The Spinoff Prize.